Cargando…
Moving Microbiome Science from the Bench to the Bedside: a Physician-Scientist Perspective
The recognition over the past decade that nearly all diseases are associated with changes in the microbiome has raised hope that microbiome-based therapeutics may cure many human ailments. Billions of dollars are being poured into microbiome-oriented biotech companies, and the coming years will undo...
Autor principal: | Surana, Neeraj K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584883/ https://www.ncbi.nlm.nih.gov/pubmed/31138724 http://dx.doi.org/10.1128/mSystems.00160-19 |
Ejemplares similares
-
Extracellular RNA in kidney disease: moving slowly but surely from bench to bedside
por: Hunter, Robert W., et al.
Publicado: (2020) -
Antineutrophil cytoplasmic antibodies-associated glomerulonephritis: From bench to bedside
por: Chen, Yong-Xi, et al.
Publicado: (2018) -
Vascular ageing: moving from bench towards bedside
por: Climie, Rachel E., et al.
Publicado: (2023) -
COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside
por: Sulzer, David, et al.
Publicado: (2020) -
T-cell Co-inhibitory Molecules in Sepsis-induced Immunosuppression: From Bench to Bedside
por: Xie, Jian-Feng, et al.
Publicado: (2017)